Stephen Knight, President & Managing Partner of F-Prime Capital, invests broadly across healthcare (therapeutics. See sector focus and contact routes.
Stephen Knight, President & Managing Partner of F-Prime Capital, invests broadly across healthcare (therapeutics, medtech, health IT) and technology (enterprise software, fintech, frontier tech) in a stage-agnostic manner, though the firm prefers early-stage deals. His distinctive thesis employs a "technical-risk-yes, regulatory-risk-no" filter, prioritizing companies with clear FDA pathways like rare diseases and gene therapy over high-regulatory categories. Notable portfolio companies he supports include Beam Therapeutics, Denali Therapeutics, and Prime Medicine, with Knight serving on the boards of several of these firms.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Cambridge.
Investors like Stephen Knight · Full investor directory · Investor access · Company funding database